PIVOTAL logo

PIVOTAL

Pharmacological Individualisation of VOriconazole Therapy for AntifungaL treatment

PIVOTAL

Pharmacological Individualisation of VOriconazole Therapy for AntifungaL treatment
Funding NIHR
Portfolio Clinical Specialties
Interventions Device
Randomised No
Status Closed
Start Date 10-Aug-2016

This is a device based study to examine the use of software to determine personalised dosing for patients with compromised imunity at risk of fungal infections.

Publications

  • Hope W, Johnstone G, Cicconi S, Felton T, Goodwin J, Whalley S, Santoyo-Castelazo A, Ramos-Martin V, Lestner J, Credidio L, Dane A, Carr DF, Pirmohamed M, Salim R, Neely M. Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study. Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02353-18. doi: 10.1128/AAC.02353-18. Print 2019 Apr. PubMed PMID: 30670416; PubMed Central PMCID: PMC6496160.
    1. https://doi.org/10.1128/AAC.02353-18